Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study
Authors
Keywords
-
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-04-30
DOI
10.1007/s00432-019-02924-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial
- (2018) Susanna Hegewisch-Becker et al. EUROPEAN JOURNAL OF CANCER
- Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer–Specific Mortality in Patients With Stage II or III Colorectal Cancer
- (2018) Peer Wille-Jørgensen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols
- (2018) Melanie Calvert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada
- (2018) Paul G Kluetz et al. LANCET ONCOLOGY
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016
- (2018) et al. JAMA Oncology
- Integration of oncology and palliative care: a Lancet Oncology Commission
- (2018) Stein Kaasa et al. LANCET ONCOLOGY
- Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer
- (2017) Alan P. Venook et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patient-reported outcomes in cancer care — hearing the patient voice at greater volume
- (2017) Thomas W. LeBlanc et al. Nature Reviews Clinical Oncology
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
- (2016) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
- (2016) Andrew Bottomley et al. LANCET ONCOLOGY
- Patient-reported outcomes in the evaluation of toxicity of anticancer treatments
- (2016) Massimo Di Maio et al. Nature Reviews Clinical Oncology
- The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review
- (2016) Thomas M. Atkinson et al. SUPPORTIVE CARE IN CANCER
- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
- (2015) N. I. Cherny et al. ANNALS OF ONCOLOGY
- First-Line Treatment of Metastatic Colorectal Cancer: Interpreting FIRE-3, PEAK, and CALGB/SWOG 80405
- (2015) Elena Elez et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making
- (2015) Jonathan R. Rees et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Systematic review recommends the European Organization for Research and Treatment of Cancer colorectal cancer–specific module for measuring quality of life in colorectal cancer patients
- (2015) Carlos K.H. Wong et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials
- (2015) Massimo Di Maio et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
- (2015) Chiara Cremolini et al. LANCET ONCOLOGY
- Patient-reported outcomes as end points and outcome indicators in solid tumours
- (2015) Angeles A. Secord et al. Nature Reviews Clinical Oncology
- A review of instrumental variable estimators for Mendelian randomization
- (2015) Stephen Burgess et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer
- (2014) Lee S. Schwartzberg et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- Identifying changes in scores on the EORTC-QLQ-C30 representing a change in patients’ supportive care needs
- (2014) Claire F. Snyder et al. QUALITY OF LIFE RESEARCH
- When Using Patient-Reported Outcomes in Clinical Practice, the Measure Matters: A Randomized Controlled Trial
- (2014) Claire F. Snyder et al. Journal of Oncology Practice
- Health-Related Quality of Life in EORTC clinical trials — 30 years of progress from methodological developments to making a real impact on oncology practice
- (2012) G. Velikova et al. EJC SUPPLEMENTS
- Pitfalls in the interpretation of standardised quality of life instruments for individual patients? A qualitative study in colorectal cancer
- (2012) Timothy R. Wilson et al. QUALITY OF LIFE RESEARCH
- Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer
- (2011) Lionel Uwer et al. Health and Quality of Life Outcomes
- The value of progression-free survival to patients with advanced-stage cancer
- (2011) Lesley J. Fallowfield et al. Nature Reviews Clinical Oncology
- The Missing Voice of Patients in Drug-Safety Reporting
- (2010) Ethan Basch NEW ENGLAND JOURNAL OF MEDICINE
- What Is Value in Health Care?
- (2010) Michael E. Porter NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer
- (2009) R.N. Whistance et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now